Andy Hsieh

facebook_page
twitter_page

Last quote by Andy Hsieh

We believe Celgene's ability to combine approved therapies in-house with either durvalumab or BGB-A317 provides the company flexibility during development and commercialization.feedback
share this quote
Jul 06 2017 China
Andy Hsieh has most recently been quoted in an article called Celgene signs deal with BeiGene for tumor cancer treatment. Andy Hsieh said, “We believe Celgene's ability to combine approved therapies in-house with either durvalumab or BGB-A317 provides the company flexibility during development and commercialization.”.
Automatically powered by Storyzy
Take our quote verification challenge and find out !
<
>
Quote Verifier
verify-icon
Check if the quote you read on social networks is authentic
facebook_page
twitter_page
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided
 
Feedback×

Quote :

Mistake :

Comments :